Planning For Better Clinical TrialsFaster, smoother and more approvable clinical trials start with you.Ben Locwin, Contributing EditorOriginal link: https://www.contractpharma.com/issues/2021-09

 CDMO Trends: End-to-End Service Providers By Patricia Van Arnum - DCAT Editorial DirectorOriginal link: https://www.dcatvci.org/7321-cdmo-trends-end-to-end-service-providers  &nbs

 Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in ChinaOriginal link: https://gh.bmj.com/content/6/9/e005519h

 Chinese CDMO sector growing but unlikely to make global impact by Dan StantonOriginal link: https://bioprocessintl.com/bioprocess-insider/global-markets/chinese-cdmo-sector-growing-but-unli

 Costs of raw material for drugs rise by up to 140%By Rupali MukherjeeOriginal link: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/costs-of-raw-material-fo

 Pharmaceuticals: dealing with generic, fake and grey market drugs in ChinaFERRANTE Intellectual PropertyBy Michele FerranteOriginal link: https://www.worldtrademarkreview.com/anti-counterfeiting

 China issues implementation measures on pharmaceutical patent linkage systemJie ZhaoWanhuida Intellectual Property | ChinaOriginal link: https://www.lexology.com/commentary/intellectual-property

 Global Active Pharmaceutical Ingredients (API) Market to Reach $265.3 Billion by 2026PROVIDED BYGlobal Industry Analysts, Inc.Original link: https://www.prnewswire.com/news-releases/gl

 Choosing and Managing a CDMOSpeed up your time-to-market, keep development costs under control and smooth the FDA approval and commercial launch process.Dana Toops, President, Avema Pharma Solut

 Global Outsourcing Trends Lonza’s Jan Vertommen talks about building global manufacturing and development networks to advance innovative, life-saving therapies.Tim Wright, Editor, Contract